Acute Coronary Syndromes

Acute coronary syndrome (ACS) is most commonly caused by a heart attack (myocardial infarction) where blood flow to the heart is suddenly blocked. This is usually caused by a blood clot from a ruptured coronary artery atherosclerotic plaque. Other causes include spontaneous coronary artery dissection (SCAD), which most commonly occurs in women. ACS is usually treated in a cath lab with angioplasty and the placement of a stent to prop the vessel open.

AI dramatically improves the detection of severe heart attacks
Researchers put an advanced AI model to the test, using it to evaluate the ECG results of more than 1,000 patients. It performed quite well.
Stem cell patch shows potential to heal heart patients—no surgery or transplant required
The new patch is implanted through a tiny incision and held in place with a biocompatible adhesive. It then helps the heart recover over time, replacing dead tissue that would typically never be able to regenerate.
COVID-19, other infections linked to major cardiovascular risks—researchers push for vaccination
Adults are three times as likely to have a heart attack or stroke after a COVID-19 infection than when they are healthy. The risks are even greater for the flu.
FDA clears new AI-enabled coronary plaque analysis software
Circle Cardiovascular Imaging, a Canadian medtech company, received the key approval for its cvi42 | Plaque platform.
A promising SELUTION: Sirolimus-eluting balloon from Cordis makes impression at TCT 2025
The SELUTION SLR Drug-Eluting Balloon was the topic of two different late-breaking clinical trials at TCT 2025. Both studies found that the device was noninferior to traditional treatments after one year. Long-term data are still needed.

Cardiologist saves fellow hiker’s life—and then saves it again

Corey Adams, MD, saved a fellow hiker's life—and the story didn't end there.

Preterm births associated with increased risk of ischemic heart disease for the mother

The study's authors tracked data from more than 2 million women.

Protein boosts heart attack recovery, could be a game-changer for patients

There are approximately 20,000 proteins in the human heart—and one of them, if administered as a drug, could help patients recover more quickly following a myocardial infarction.

Spectacular science: 3D model offers breathtaking look at what happens during a heart attack

So what, exactly, occurs inside the human heart during a myocardial infarction?

Gene-editing specialists raise $63M to combat coronary heart disease

Verve Therapeutics, a healthcare company focused on improving cardiovascular outcomes through gene-editing technology, has raised $63 million in Series A2 financing.

Cardiologists urge heart disease patients to seek emergency care when necessary

Hospitals throughout the United States have reported that a general fear of COVID-19 has led to significant drops in patients presenting with heart attack symptoms and other cardiovascular issues.

FDA approves use of ticagrelor for high-risk CAD patients

Ticagrelor has been approved by the FDA for reducing the risk of a first heart attack or stroke in high-risk coronary artery disease (CAD) patients.

Evolocumab improves cardiovascular outcomes for patients with a recent MI

Evolocumab is an effective treatment option for patients with a recent myocardial infarction (MI), according to new findings published in JAMA Cardiology.

Acute Coronary Syndromes

AI dramatically improves the detection of severe heart attacks

Stem cell patch shows potential to heal heart patients—no surgery or transplant required

COVID-19, other infections linked to major cardiovascular risks—researchers push for vaccination

FDA clears new AI-enabled coronary plaque analysis software

A promising SELUTION: Sirolimus-eluting balloon from Cordis makes impression at TCT 2025